Semaglutide
A glucagon-like peptide-1 (GLP-1) receptor agonist studied for metabolic and glycemic research.
Research Use Only. This product is intended for laboratory research purposes only and is not for human consumption. Not for sale to minors.
Product Description
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is a 94% homologous analogue of human GLP-1, modified to extend its half-life. Research has extensively studied its effects on glucose metabolism, insulin secretion, appetite regulation, and body weight.
Research Information
Extensive research on semaglutide has demonstrated its ability to stimulate insulin secretion in a glucose-dependent manner, suppress glucagon release, and slow gastric emptying. Studies have shown significant effects on appetite regulation through central nervous system pathways. Research has also explored cardiovascular outcomes.
Dosage Guidance
Research protocols vary widely. Standard vials contain 2mg or 5mg lyophilized powder. All dosing information is for research reference only.